Government administered pricing at the Medicare level for all purchasers of health care services – as suggested in a recent opinion piece that appeared in the Washington Post titled, “There’s a genuine solution to our health-care problem” – would disrupt the fragile financing system that ensures the provision of access to essential services for all Americans, and would prevent private-sector innovation that supports medical research, education and the creation of medical miracles.  It would also threaten access to basic care for those in vulnerable communities.

 

For Medicare, hospitals received payment of only 87 cents for every dollar spent caring for Medicare patients in 2016.  Despite this, hospitals have kept growth of prices for insurers under 2% for each of the last four years. This is despite rising input costs, such as prescription drugs. For instance, hospital spending per admission on prescription drugs rose 38.7% from 2013 to 2105.

 

There is a better solution.  Over the years, hospitals and health systems have strongly supported health coverage for all. Strengthening health care exchanges providing subsidized coverage for the uninsured, combined with expansion of the Medicaid program, remains the best way of extending coverage to more people.   

 

Finally, rapid changes in the health care field require hospitals and health systems to join together with physicians, and other partners to explore new ways to enhance quality, reduce costs, and provide more convenient access to care to meet patients’ needs.

 

Related News Articles

Headline
The AHA collaborated with LCMC Health in New Orleans to spotlight innovative efforts that extend care beyond hospital walls. LCMC Health supports families…
Headline
Cigna’s Evernorth division Oct. 27 announced a new, rebate-free pharmacy benefit model, beginning in 2027, that would reduce monthly prescription drug costs by…
Headline
A new report from KFF reveals that Medicare Advantage enrollees had access to just 48% of the physicians available to Traditional Medicare beneficiaries in…
Headline
The median net launch price for 154 new drugs increased 51% between 2022 and 2024, after accounting for inflation and discounts, according to a report released…
Headline
The AHA Oct. 23 recommended changes to the Centers for Medicare & Medicaid Services’ Wasteful and Inappropriate Services Reduction model to address…
Headline
The Centers for Medicare & Medicaid Services has released an operational guide for Medicare-enrolled providers and suppliers on the Wasteful and…